HIGHLIGHTS
- who: Xuan Cao et al. from the Wilmer Eye InstituteHopkins University of Dentistry, Baltimore, Maryland, USA have published the Article: CLINICAL MEDICINE Aflibercept more effectively weans patients with neovascular age-related macular degeneration off therapy compared with bevacizumab, in the Journal: (JOURNAL)
- what: An alternative approach to optimize the efficacy of a drug for each patient while minimizing the number of injections is the treat-and-extend (TAE) protocol, in which the response of an individual patient to treatment is used to determine whether the interval between treatments can be extended for that particular patient . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.